[1] ASHBURN T T, THOR K B. Drug repositioning:identifying and developing new uses for existing drugs[J]. Nat Rev Drug Discov, 2004, 3(8):673-683. [2] NOSENGO N. Can You teach old drugs new tricks-[J]. Nature, 2016, 534(7607):314-316. [3] ENEANYA D I, BIANCHINE J R, DURAN D O, et al. The actions of metabolic fate of disulfiram[J]. Annu Rev Pharmacol Toxicol, 1981, 21:575-596. [4] CVEK B. Nonprofit drugs as the salvation of the world's healthcare systems:the case of Antabuse (disulfiram)[J]. Drug Discov Today, 2012, 17(9/10):409-412. [5] CEN D Z, BRAYTON D, SHAHANDEH B, et al. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells[J]. J Med Chem, 2004, 47(27):6914-6920. [6] CHEN D, CUI Q C, YANG H J, et al. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity[J]. Cancer Res, 2006, 66(21):10425-10433. [7] GUO X X, XU B, PANDEY S, et al. Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines[J]. Cancer Lett, 2010, 290(1):104-113. [8] MARIKOVSKY M, NEVO N, VADAI E, et al. Cu/Zn superoxide dismutase plays a role in angiogenesis[J]. Int J Cancer, 2002, 97(1):34-41. [9] ILJIN K, KETOLA K, VAINIO P, et al. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth[J]. Clin Cancer Res, 2009, 15(19):6070-6078. [10] LIU P, BROWN S, GOKTUG T, et al. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells[J]. Br J Cancer, 2012, 107(9):1488-1497. [11] LIU P, KUMAR I S, BROWN S, et al. Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells[J]. Br J Cancer, 2013, 109(7):1876-1885. [12] LIU P, WANG Z P, BROWN S, et al. Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo[J]. Oncotarget, 2014, 5(17):7471-7485. [13] WANG W G, MCLEOD H L, CASSIDY J. Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines[J]. Int J Cancer, 2003, 104(4):504-511. [14] TAWARI P E, WANG Z P, NAJLAH M, et al. The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells[J]. Toxicol Res (Camb), 2015, 4(6):1439-1442. [15] BUTCHER K, KANNAPPAN V, KILARI R S, et al. Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line[J]. BMC Cancer, 2018, 18(1):753. [16] SULLIVAN J F, BLOTCKY A J, JETTON M M, et al. Serum levels of selenium, calcium, copper magnesium, manganese and zinc in various human diseases[J]. J Nutr, 1979, 109(8):1432-1437. [17] RAE C, TESSON M, BABICH J W, et al. The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells[J]. J Nucl Med, 2013, 54(6):953-960. [18] 胡硕, 胡成平. 线粒体与细胞凋亡的研究进展[J]. 国际呼吸杂志, 2006(6):463-466, 470. |